NCT03953183View on ClinicalTrials.gov

Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

August 14, 2019

Study Completion Date

October 25, 2019

Conditions
Pharmacokinetics
Interventions
OTHER

P3P-1mg

P3P-1mg (P3P product containing 1mg of nicotine.)

OTHER

P3P-2mg

P3P-2mg (P3P product containing 2mg of nicotine.)

Trial Locations (1)

196143

LLC Scientific Research Center Eco-Safety, Saint Petersburg

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT03953183 - Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it | Biotech Hunter | Biotech Hunter